Pay in 4 interest-free payments of $6.96 Learn more
Ships within 48 hours · Estimated delivery Sep 14 - Sep 19
Clinical trials show that approximately 2540% of total weight lost on semaglutide comes from lean body mass, which includes muscle, bone, and water
Quanta Pharma Retatrutide 30mg Specifications Retatrutide 30mg by Quanta Pharma Quanta Pharma Retatrutide Research Benefits Triple receptor action - Targets GLP-1, GIP, and Glucagon receptors for the most comprehensive metabolic research available Superior weight management - Clinical trials showed greater weight reduction compared to dual agonists like Tirzepatide Enhanced fat oxidation - Glucagon receptor activation promotes direct fat burning and energy expenditure Glycemic control - Researched for improving insulin sensitivity and glucose metabolism Extended half-life - Approximately 6 days allows for once-weekly administration in research protocols How Quanta Pharma Retatrutide Works Quanta Pharma Retatrutide is a triple agonist peptide that simultaneously activates three key receptors involved in metabolic regulation: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and the Glucagon receptor
November 16, 2019
PCPs Cautious with GLP-1 Prescriptions Despite increasing patient demand, PCPs remain generally cautious when prescribing GLP-1 medications
US$ 22.17
US$ 28.73
US$ 22.04
US$ 20.73
US$ 23.87
US$ 29.75
